Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?
Author(s) -
Rita Guedes,
Inês Leite,
Armando Baptista,
Natividade Rocha
Publication year - 2012
Publication title -
case reports in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 20
eISSN - 1687-9627
pISSN - 1687-9635
DOI - 10.1155/2012/854738
Subject(s) - necrobiosis lipoidica , medicine , dermatology , etanercept , adverse effect , surgery , tumor necrosis factor alpha , diabetes mellitus , immunology , endocrinology
Necrobiosis lipoidica is a rare granulomatous and inflammatory disease. Its management is particularly difficult when ulceration is present. The authors describe the clinical case of a 65-year-old female patient with necrobiosis lipoidica, who had been submitted in the past to several topical and systemic treatments with little or no improvement. She started treatment with subcutaneous etanercept and showed significant improvement without adverse events until today. The aim of this article is to report a valid and efficient alternative treatment to recalcitrant cases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom